MeSH Browser

MeSH Heading: Megestrol Acetate
Tree Number(s): D04.210.500.745.432.531.500
Unique ID: D019290
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D019290
Scope Note: Megestrol acetate is a progestogen with actions and uses similar to those of the progestogens in general. It also has anti-androgenic properties. It is given by mouth in the palliative treatment or as an adjunct to other therapy in endometrial carcinoma and in breast cancer. Megestrol acetate has been approved to treat anorexia and cachexia. (From Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995)
Entry Term(s): Apo-Megestrol; Borea; Lin-Megestrol; Maygace; Megace; Megefren; Megestat; Megostat; Mestrel; Nu-Megestrol
Pharm Action: Antineoplastic Agents, Hormonal
Appetite Stimulants
Registry Numbers: TJ2M0FR8ES; 0
Related Numbers: 51154-23-5
CAS Type 1 Name: Pregna-4,6-diene-3,20-dione, 17-(acetyloxy)-6-methyl-
Previous Indexing: Megestrol/analogs & derivatives (1980-1996)
Public MeSH Note: 97
History Note: 97;
Date Established: 1997/01/01
Date of Entry: 1996/06/10
Revision Date: 2017/05/24

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Megestrol Acetate MeSH Descriptor Data 2025